Strata Skin Sciences, Inc.

SSKN Healthcare Medical Devices

Strata Skin Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $30.7 million, down 8.54% from fiscal 2024. In the quarter to December 2025, revenue fell 2.97%, EPS grew 111.5%, free cash flow fell 376.9% and total debt rose 1.03%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.00 0.00 NaN
Market cap
$1.0M
P/E
0.0×
Fwd P/E
−0.1×
Dividend yield
—
F-score
5/9
Altman Z
−11.48
Beneish M
−3.33
Dividend safety
n/a

Strata Skin Sciences, Inc. (SSKN) P/E ratio

Alert me on P/E ratio

Strata Skin Sciences, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 1.3× (April 2019) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Dec 2025 0.0× —
Sep 2025 0.0× —
Jun 2025 0.0× —
Mar 2025 0.0× —
40 more quarters

Against its own ten years

Low 0.0× High 1.3×
Ten-year median 0.0×
Current reading's percentile 94

P/E ratio against peers

Company P/E ratio
DHAI DIH Holding US, Inc. compare n/m
DYNTQ Dynatronics Corporation compare n/m
FEED ENvue Medical, Inc. compare n/m
SSKN Strata Skin Sciences, Inc. n/m
NUWE Nuwellis, Inc. compare n/m
AFIB Acutus Medical, Inc. compare n/m
VJET Flyte Aviation, Inc. compare n/m
THMO ThermoGenesis Holdings, Inc. compare n/m
PFSA PROFUSA, Inc. compare 0.0×
Medical Devices industry median 23.2×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on SSKN